These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 15876425

  • 1. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
    Sánchez-Hidalgo M, Martín AR, Villegas I, Alarcón De La Lastra C.
    Biochem Pharmacol; 2005 Jun 15; 69(12):1733-44. PubMed ID: 15876425
    [Abstract] [Full Text] [Related]

  • 2. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M, Martín AR, Villegas I, de la Lastra CA.
    Eur J Pharmacol; 2007 May 21; 562(3):247-58. PubMed ID: 17343846
    [Abstract] [Full Text] [Related]

  • 3. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation.
    Villegas I, Martín AR, Toma W, de la Lastra CA.
    Eur J Pharmacol; 2004 Nov 28; 505(1-3):195-203. PubMed ID: 15556153
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D, Zeng BX, Zhang SH, Yao SL.
    Inflamm Res; 2005 Nov 28; 54(11):464-70. PubMed ID: 16307220
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
    Ramakers JD, Verstege MI, Thuijls G, Te Velde AA, Mensink RP, Plat J.
    J Clin Immunol; 2007 May 28; 27(3):275-83. PubMed ID: 17510806
    [Abstract] [Full Text] [Related]

  • 9. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat.
    Konturek PC, Brzozowski T, Kania J, Kukharsky V, Bazela K, Kwiecien S, Harsch I, Konturek SJ, Hahn EG.
    Scand J Gastroenterol; 2003 May 28; 38(5):468-76. PubMed ID: 12795455
    [Abstract] [Full Text] [Related]

  • 10. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
    Celinski K, Dworzanski T, Korolczuk A, Piasecki R, Slomka M, Madro A, Fornal R.
    J Physiol Pharmacol; 2011 Jun 28; 62(3):347-56. PubMed ID: 21893696
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug 28; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rosiglitazone reduces the inflammatory response in a model of vascular injury in rats.
    Rinaldi B, Pieri L, Donniacuo M, Cappetta D, Capuano A, Domenici L, Carnuccio R, Romagnoli P, Filippelli A, Rossi F.
    Shock; 2009 Dec 28; 32(6):638-44. PubMed ID: 19333142
    [Abstract] [Full Text] [Related]

  • 16. PARP inhibition reduces acute colonic inflammation in rats.
    Sánchez-Fidalgo S, Villegas I, Martín A, Sánchez-Hidalgo M, Alarcón de la Lastra C.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):216-23. PubMed ID: 17374531
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats.
    García-Bueno B, Madrigal JL, Lizasoain I, Moro MA, Lorenzo P, Leza JC.
    Biol Psychiatry; 2005 Apr 15; 57(8):885-94. PubMed ID: 15820709
    [Abstract] [Full Text] [Related]

  • 18. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
    Nakase H, Okazaki K, Tabata Y, Uose S, Ohana M, Uchida K, Nishi T, Debreceni A, Itoh T, Kawanami C, Iwano M, Ikada Y, Chiba T.
    J Pharmacol Exp Ther; 2001 Jun 15; 297(3):1122-8. PubMed ID: 11356937
    [Abstract] [Full Text] [Related]

  • 19. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents microparticle-induced vascular hyporeactivity through the regulation of proinflammatory proteins.
    Tesse A, Al-Massarani G, Wangensteen R, Reitenbach S, Martínez MC, Andriantsitohaina R.
    J Pharmacol Exp Ther; 2008 Feb 15; 324(2):539-47. PubMed ID: 18039959
    [Abstract] [Full Text] [Related]

  • 20. Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist.
    Linard C, Grémy O, Benderitter M.
    J Pharmacol Exp Ther; 2008 Mar 15; 324(3):911-20. PubMed ID: 18077625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.